Our Critical Care Division is pioneering excellence in critical care pharmaceutical services, dedicated to providing specialized pharmaceutical care to patients in intensive care units (ICUs) and other critical care settings. With an unwavering commitment to patient safety and multidisciplinary collaboration, we endeavor to elevate the standard of care in critical situations.
Our division offers a comprehensive array of critical care therapies meticulously designed to address the intricate medical needs of critically ill patients. These therapies encompass a broad spectrum of interventions, including intravenous medications for pain management, infection control, and hemodynamic stabilization. Additionally, we provide sedation and analgesia tailored to ensure patient comfort while minimizing risks. Our evidence-based antibiotic regimens combat severe infections, while vasopressors and inotropes stabilize blood pressure and cardiac output in patients experiencing shock or cardiovascular instability.
Moreover, we manage anticoagulation therapy to prevent blood clots and minimize thromboembolic events. Our nutritional support interventions are customized to meet the unique metabolic demands of critically ill patients, encompassing enteral and parenteral nutrition strategies. Respiratory support, including mechanical ventilation and oxygen therapy, is meticulously administered to patients facing acute respiratory failure. Renal replacement therapies, such as hemodialysis and continuous renal replacement therapy (CRRT), are employed to manage acute kidney injury and maintain fluid and electrolyte balance.
